Medius Holdings Co., Ltd. (3154) AI Stock Analysis

• Market Cap: ¥21.50B
• Dividend Yield: 2.17%
• Average Volume (3M): 19.70K
• Price to Earnings (P/E): 15.9
• Beta (1Y): 0.67
• Revenue Growth: 14.12%
• EPS Growth: 56.92%
• Country: JP
• Employees: 2,517
• Sector: Healthcare
• Sector Strength: 44
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 43.40
• Shares Outstanding: 22,238,216
• 10 Day Avg. Volume: 30,600
• 30 Day Avg. Volume: 19,696
• PEG Ratio: -0.64
• Price to Book (P/B): 1.03
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 63.81
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 72 Outperform
• Price Target: ¥1,072.00 ▲(10.86%Upside)

Medius Holdings Co., Ltd. receives a strong score driven by solid financial performance and favorable technical analysis indicators. Although cash flow volatility and moderate valuation metrics are concerns, the company's stable growth and operational strength position it well within the industry.

Medius Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Medius Holdings Co., Ltd. (3154) is a Japan-based company primarily engaged in the wholesale distribution of medical devices and equipment. The company operates through various sectors including the sale of medical supplies, management of medical facilities, and provision of medical-related services. Medius Holdings focuses on delivering high-quality products and solutions that cater to the healthcare industry, aiming to improve patient care and operational efficiencies in medical institutions.

How the Company Makes Money

Medius Holdings Co., Ltd. generates revenue through the wholesale distribution of medical devices and equipment to hospitals, clinics, and other healthcare providers. The company's revenue model is centered around the procurement and supply of a wide range of medical products, ranging from basic supplies to advanced medical devices. Key revenue streams include direct sales to healthcare institutions, long-term contracts with hospitals, and partnerships with medical equipment manufacturers. Additionally, the company may engage in collaborative ventures and alliances that enhance its distribution network and expand its market reach, thereby contributing to its earnings.

Medius Holdings Co., Ltd. Financial Statement Overview

Summary

Medius Holdings Co., Ltd. demonstrates strong revenue growth and consistent profitability margins. However, cash flow fluctuations, particularly in free cash flow, pose a risk that needs attention for sustained financial health.

Income Statement

Medius Holdings Co., Ltd. shows a strong revenue growth trajectory with recent TTM data indicating a rise in total revenue. The gross profit margin is stable, reflecting efficient cost management. However, the net profit margin has shown some volatility, which could be a concern. EBIT and EBITDA margins are consistent, suggesting operational stability.

Balance Sheet

The company's balance sheet reveals a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The return on equity is healthy, demonstrating effective utilization of shareholder funds. The equity ratio is satisfactory, reflecting a solid asset base supported by equity.

Cash Flow

Cash flow analysis shows fluctuations in free cash flow, influenced by capital expenditure dynamics. Despite operating cash flow being zero in the latest TTM data, previous periods have shown positive cash flow generation. The company needs to focus on sustaining free cash flow for long-term stability.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
275.78B	259.79B	239.05B	221.69B	246.79B	210.39B
	Gross Profit
32.28B	31.09B	29.31B	27.42B	25.20B	22.27B
	EBIT
1.39B	1.33B	1.88B	2.27B	2.66B	1.10B
	EBITDA
3.62B	3.86B	4.27B	3.80B	4.14B	2.11B
	Net Income Common Stockholders
1.03B	1.12B	1.50B	1.87B	2.07B	951.36M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
14.00B	13.66B	10.36B	9.11B	12.67B	8.54B
	Total Assets
119.80B	114.83B	97.46B	92.95B	84.44B	69.97B
	Total Debt
25.23B	24.17B	19.57B	17.82B	11.60B	9.31B
	Net Debt
11.24B	10.53B	9.24B	8.71B	-1.03B	817.60M
	Total Liabilities
99.82B	95.09B	78.88B	75.65B	68.59B	56.10B
	Stockholders Equity
19.98B	19.74B	18.57B	17.31B	15.84B	13.87B
Cash Flow		Free Cash Flow
0.00	261.12M	300.65M	-8.49B	2.93B	185.14M
	Operating Cash Flow
0.00	1.92B	1.22B	-3.90B	6.85B	1.17B
	Investing Cash Flow
0.00	-2.67B	-862.94M	-4.82B	-4.62B	138.45M
	Financing Cash Flow
0.00	4.01B	862.90M	5.21B	1.90B	787.57M

Medius Holdings Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 967.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Positive. The current price of 967 is above the 20-day moving average (MA) of 966.00, above the 50-day MA of 945.26, and above the 200-day MA of 872.84, indicating a neutral trend. The MACD of 5.39 indicates Positive momentum. The RSI at 50.33 is Neutral, neither overbought nor oversold. The STOCH value of 32.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3154.

Medius Holdings Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4556	84 Outperform	¥5.06B	8.14		2.83%	4.93%	-0.26%
7980	76 Outperform	¥5.67B	7.26		1.90%	8.60%	33.64%
3154	72 Outperform	¥21.50B	15.93		2.17%	14.12%	56.92%
7743	64 Neutral	¥13.44B	12.30		3.35%	2.58%	-53.08%
7979	61 Neutral	¥73.15B	16.87		3.02%	15.55%	42.14%
Sector *	54 Neutral	$5.38B	3.40	-45.06%	3.28%	16.75%	-0.02%
7702	53 Neutral	¥10.33B	116.43		4.02%	6.83%	―

Medius Holdings Co., Ltd. Corporate Events

Medius Holdings Reports Strong Q3 Financial Growth Amid Strategic Expansion

Medius Holdings Co., Ltd. reported significant financial growth for the third quarter ended March 31, 2025, with net sales increasing by 13.7% and operating profit rising by 22.6% compared to the previous year. The inclusion of two new companies in its consolidation scope reflects Medius Holdings’ strategic expansion, potentially enhancing its market position and offering improved services to stakeholders.

Medius Holdings Restructures Logistics Division for Enhanced Efficiency

Medius Holdings Co., Ltd. announced a strategic restructuring of its logistics division through a simplified absorption-type company split, effective July 1, 2025. This move aims to enhance logistics management, standardize processes, and invest in logistics solutions to improve productivity and reduce costs, thereby strengthening the company’s operational efficiency and market position.